CPHI Financial Facts
Cost of revenue: 2.7MNet income: -1.75M
See Full Income Statement
Total Current Liabilities: 12.95M
Advances to suppliers: 2.61M
See Full Balance Sheet
China Pharma Holdings (CPHI) Earnings
|
Expand Research on CPHI
Next EPS Date | N/A | EPS Growth Rate | N/A |
---|---|---|---|
Average EPS % Beat Rate | 0.0% | Revenue Growth Rate | N/A |
Average % Move 1-Wk after EPS | -1.9% | Normal Earnings Time | Before Open |
Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
---|---|---|---|---|---|---|---|---|---|---|---|
5/18/23 | Q123 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
3/31/23 | Q422 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
11/18/22 | Q322 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
8/18/22 | Q222 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
8/29/22 | Q222 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
8/22/22 | Q222 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
8/14/20 | Q220 | $0.00 | N/A | N/A | $3.77M | $2.57M | N/A | Details | |||
3/31/20 | Q319 | $0.00 | N/A | N/A | N/A | N/A | N/A | Details |